James Paul O'Neill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
James Paul O'Neill has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Aizuri Murad
Department of Dermatology, School of Medicine, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland
1 shared publicationBen Dean
Department of Transplant Urology and Nephrology, National Kidney Transplant Service, Beaumont Hospital Dublin, Dublin, Ireland
1 shared publication- Brendan Conlon
Neuromod Devices Limited, Dublin D08 R2YP, Ireland
1 shared publication Conall Fitzgerald
Department of Otolaryngology, Head and Neck Surgery, Beaumont Hospital & The Royal College of Surgeons in Ireland, Dublin, Ireland
1 shared publicationDiarmaid D. Houlihan
National Liver Transplant Center, St Vincent's University Hospital, Dublin, Ireland
1 shared publicationDilly Little
Department of Transplant Urology and Nephrology, National Kidney Transplant Service, Beaumont Hospital Dublin, Dublin, Ireland
1 shared publication
Latest Publications
- 16 July 2019
- Published by Wiley in Clinical Transplantation
- Vol. 33 (10) , e13669
Post‐transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group
Objective: Solid organ transplant recipients are at increased risk of cancer compared to the general population. To date, this risk in Ireland has not been investigated. We conducted a national registry study of cancer incidence following solid organ transplantation.Methods: National centers for solid organ transplantation supplied their respective registry databases to cross‐reference with episodes of malignancy from the National Cancer Registry Ireland (NCRI) between 1994 and 2014. Standardized incidence of cancer post‐transplant was compared to the general population by means of standardized incidence ratios (SIRs), and between solid organ transplant types by incidence rate ratios.Results: A total of 3346 solid organ transplant recipients were included in this study. Kidney transplant recipients constituted the majority of participants (71.2%), followed by liver (16.8%), heart (6.4%), and lung (5.6%) transplants. The most common cancers within the composite of all transplant recipients included the following (SIR [95% CI]): squamous and basal cell carcinoma (20.05 [17.97, 22.31] and 7.16 [6.43, 7.96], respectively), non‐Hodgkin lymphoma (6.23 [4.26, 8.59]), and renal cell carcinoma (3.36 [1.96, 5.38]).Conclusions: This study reports the incidence of cancer following solid organ transplantation in Ireland. These results have significant national policy implications for surveillance, and early diagnosis in this patient group.
- 16 July 2019
- Published by Wiley in Clinical Transplantation
- Vol. 33 (10) , e13669
Post‐transplant malignancy in solid organ transplant recipients in Ireland, The Irish Transplant Cancer Group
Objective: Solid organ transplant recipients are at increased risk of cancer compared to the general population. To date, this risk in Ireland has not been investigated. We conducted a national registry study of cancer incidence following solid organ transplantation.Methods: National centers for solid organ transplantation supplied their respective registry databases to cross‐reference with episodes of malignancy from the National Cancer Registry Ireland (NCRI) between 1994 and 2014. Standardized incidence of cancer post‐transplant was compared to the general population by means of standardized incidence ratios (SIRs), and between solid organ transplant types by incidence rate ratios.Results: A total of 3346 solid organ transplant recipients were included in this study. Kidney transplant recipients constituted the majority of participants (71.2%), followed by liver (16.8%), heart (6.4%), and lung (5.6%) transplants. The most common cancers within the composite of all transplant recipients included the following (SIR [95% CI]): squamous and basal cell carcinoma (20.05 [17.97, 22.31] and 7.16 [6.43, 7.96], respectively), non‐Hodgkin lymphoma (6.23 [4.26, 8.59]), and renal cell carcinoma (3.36 [1.96, 5.38]).Conclusions: This study reports the incidence of cancer following solid organ transplantation in Ireland. These results have significant national policy implications for surveillance, and early diagnosis in this patient group.
- 29 July 2011
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 180 (4) , 841-844
Major otology day case surgery: viable, cost efficient and safe
There has been no study or institution in Ireland promoting major ear surgery performed as a day case procedure in adults. At present, there is a strong political and financial drive for increased elective day case surgery and also a public responsibility to reduce surgical waiting times.
- 29 July 2011
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 180 (4) , 841-844
Major otology day case surgery: viable, cost efficient and safe
There has been no study or institution in Ireland promoting major ear surgery performed as a day case procedure in adults. At present, there is a strong political and financial drive for increased elective day case surgery and also a public responsibility to reduce surgical waiting times.